Compare ABUS & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABUS | FWRD |
|---|---|---|
| Founded | 2005 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 888.5M | 871.2M |
| IPO Year | N/A | 1993 |
| Metric | ABUS | FWRD |
|---|---|---|
| Price | $4.17 | $27.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 3 |
| Target Price | $5.00 | ★ $35.00 |
| AVG Volume (30 Days) | ★ 2.1M | 587.6K |
| Earning Date | 03-26-2026 | 02-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $14,606,000.00 | ★ $2,496,734,000.00 |
| Revenue This Year | $125.30 | $2.78 |
| Revenue Next Year | N/A | $4.76 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 116.64 | 14.54 |
| 52 Week Low | $2.71 | $9.79 |
| 52 Week High | $5.10 | $32.47 |
| Indicator | ABUS | FWRD |
|---|---|---|
| Relative Strength Index (RSI) | 48.44 | 47.15 |
| Support Level | $3.85 | $25.94 |
| Resistance Level | $4.26 | $31.18 |
| Average True Range (ATR) | 0.33 | 1.56 |
| MACD | 0.02 | -0.32 |
| Stochastic Oscillator | 58.18 | 27.00 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.